Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT05769959What this trial is testingStudy of RO7515629 in Participants With HLA-G Positive Solid TumorsWho this might be right forRenal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more Hoffmann-La Roche 3
Testing effectiveness (Phase 2)UnknownNCT01763450What this trial is testingBevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal CancerWho this might be right forLiver MetastasesColorectal Cancer Liaoning Cancer Hospital & Institute 100
Large-scale testing (Phase 3)UnknownNCT03175016What this trial is testingIrinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal CancerWho this might be right forColon Cancer Liver Metastasis Tianjin Medical University Cancer Institute and Hospital 200
Large-scale testing (Phase 3)Study completedNCT00284258What this trial is testingPhase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerWho this might be right forColorectal Cancer Taiho Pharmaceutical Co., Ltd. 426
Testing effectiveness (Phase 2)Looking for participantsNCT06605430What this trial is testingMedical Cannabis in Patients With Advanced Pancreatic and Colorectal CancerWho this might be right forPancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic HealthPartners Institute 64
Early research (Phase 1)Ended earlyNCT04627142What this trial is testingTest Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) MutationWho this might be right forMetastatic Colorectal Cancer (CRC) Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Looking for participantsNCT07653685What this trial is testingA Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.Who this might be right forColorectal Cancer Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT07589517What this trial is testingDual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal CancerWho this might be right forColorectal CancerMetastatic Colorectal AdenocarcinomaUnresectable Colorectal Cancer Beijing Biotech 48
Testing effectiveness (Phase 2)UnknownNCT03992456What this trial is testingPanitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerWho this might be right forMetastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more Academic and Community Cancer Research United 12
Early research (Phase 1)Study completedNCT03761017What this trial is testingMGD019 DART® Protein in Unresectable/Metastatic CancerWho this might be right forSquamous Cell Non Small Cell Lung CancerProstate Cancer MetastaticCutaneous Melanoma+3 more MacroGenics 162
Testing effectiveness (Phase 2)UnknownNCT05340231What this trial is testingAn Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)Who this might be right forColorectal Cancer Gang Wu 100
Testing effectiveness (Phase 2)Study completedNCT02316028What this trial is testingPhase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)Who this might be right forLiver MetastasisColorectal Cancer Universitair Ziekenhuis Brussel 11
Testing effectiveness (Phase 2)WithdrawnNCT03069950What this trial is testingStudy of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the LiverWho this might be right forColorectal Adenocarcinoma Metastatic to the Liver Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06231017What this trial is testingAdebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal CancerWho this might be right forMetastatic Colorectal Cancer The First Affiliated Hospital of Zhengzhou University 36
Testing effectiveness (Phase 2)Ended earlyNCT00003485What this trial is testingAntineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon CancerWho this might be right forColon Cancer Burzynski Research Institute 15
Large-scale testing (Phase 3)Study completedNCT00008060What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Medical Research Council
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Early research (Phase 1)Ended earlyNCT02408861What this trial is testingNivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more National Cancer Institute (NCI) 79